Delecite

2024 Author: Rachel Wainwright | [email protected]. Last modified: 2023-12-15 07:39

Instructions for use:

1. Release form and composition
2. Indications for use
3. Contraindications
4. Method of application and dosage
5. Side effects
6. Special instructions
7. Drug interactions
8. Analogs
9. Terms and conditions of storage
10. Terms of dispensing from pharmacies

Delecite is a nootropic drug, a centrally acting cholinomimetic.

Release form and composition

Dosage forms:

capsules: gelatinous, oval, with a soft, opaque yellow shell, inside the capsules - a colorless solution with a viscous structure (14 pcs. in a blister, 1 blister in a cardboard box);
solution for infusion and intramuscular (i / m) administration: clear, colorless liquid (4 ml in an ampoule, in a blister strip packaging 3 or 5 ampoules, in a cardboard box 1 package);
oral solution: colorless liquid with a transparent structure (7 ml in a glass bottle of dark color, in a cardboard box of 10 bottles).

1 capsule contains:

active substance: choline alfoscerate - 0.4 g;
auxiliary components: glycerol, purified water;
shell composition: titanium dioxide (E171), esitol, sodium methyl parahydroxybenzoate, sorbitan, sodium propyl parahydroxybenzoate, iron dye yellow oxide (E172), gelatin.

1 ampoule contains:

active substance: choline alfoscerate - 1 g;
auxiliary component: water for injection.

1 bottle contains:

active substance: choline alfoscerate - 0.6 g;
auxiliary components: sodium saccharinate, methyl parahydroxybenzoate, orange flavor, propyl parahydroxybenzoate, purified water.

Indications for use

The use of Delecite is indicated in the complex therapy of the following conditions:

psychoorganic syndrome in degenerative pathologies and involutional processes in the cerebral cortex or cerebrovascular insufficiency, including primary and secondary senile cognitive impairments;
multi-infarction dementia.

Contraindications

acute stage of hemorrhagic stroke;
period of pregnancy;
breast-feeding;
childhood;
individual intolerance to the components of the drug.

Method of administration and dosage

Capsules

Capsules are taken orally before meals with plenty of water.

Recommended dosage: 1 pc. 3 times a day. The duration of the course is 90-180 days.

Solution for infusion and i / m administration

The solution is intended for intravenous (intravenous) drip or intramuscular injection in acute conditions or the inability to take the drug inside.

A solution for intravenous administration is prepared by dissolving the contents of one ampoule in 50 ml of 0.9% sodium chloride solution, the infusion rate should not exceed 60–80 drops per minute.

Recommended dosage: 1 ampoule per day for 10 days, then the patient is transferred to oral administration of the drug. The duration of the general course of treatment is 90-180 days.

Oral solution

The solution is taken orally before meals with the required amount of water.

Recommended dosage: 1 bottle 2 times a day for 90-180 days.

Side effects

from the nervous system: drowsiness, insomnia, headache, dizziness, aggressiveness, cerebral ischemia, nervousness;
from the digestive system: dryness of the oral mucosa, constipation, diarrhea, pharyngitis;
dermatological reactions: skin rash;
others: allergic reactions, increased urination.

In addition, there are undesirable effects characteristic of each of the dosage forms separately.

Capsules and oral solution

from the digestive system: stomach ulcer, gastritis;
from the nervous system: convulsions, hyperkinesia.

Solution for infusion and i / m administration

dermatological reactions: urticaria;
from the nervous system: anxiety;
others: pain at the injection site.

special instructions

During the period of application of Delecite, care must be taken when driving various mechanisms or vehicles.

Drug interactions

The interaction of the drug with other drugs has not been established.

Analogs

Delecite analogs are: capsules - Cerepro, Cereton, Gliatilin, Cholytilin; solution for infusion and intramuscular injection - Choline Alfoscerat, Nookholin Rompharm, Cereton, Cerepro.

Terms and conditions of storage

Keep out of the reach of children.

Store at temperatures up to 25 ° C, solution for infusion and intramuscular injection - in a dark place.

Shelf life: capsules and oral solution - 3 years, solution for infusion and intramuscular injection - 2 years.

Terms of dispensing from pharmacies

Dispensed by prescription.

Information about the drug is generalized, provided for informational purposes only and does not replace the official instructions. Self-medication is hazardous to health!